Acrylamide (ACR) is a cumulative neurotoxin which causes axonal degeneratio
n in animals and man. Industrial workers exposed to ACR have been reported
to suffer from a variety of central and peripheral neuropathological sympto
ms including numbness of hands and feet, skin peeling and muscular weakness
of legs. These reports suggest that the body burden of ACR may be a risk f
actor in recovery patterns following neurotrauma. The present study was des
igned to assess the effect of ACR on neurological recovery following spinal
cord injury (SCI) in rats.
Male Sprague-Dawley rats weighing 200-230 g were anaesthetised with chloral
hydrate and laminectomy was performed at T 7-8 level leaving the dura inta
ct. A compression plate (2.2 x 5.0 mm) loaded with a weight of 35 g was pla
ced on the exposed cord for 5 minutes. Animals were divided into seven grou
ps of eight rats each. The animals in Group 1 served as control whereas rat
s in Group 2 underwent laminectomy alone (sham). The rats in Group 3 to 6 w
ere subjected to SCI as mentioned above. Animals in Groups 4, 5 and 6 also
received ACR in the doses of 10 mg/kg, 20 mg/kg and 40 mg/kg, i.p., respect
ively in addition to SCI, whereas the rats in Group 7 received ACR alone at
a dose of 40 mg/kg body weight. The first dose of ACR was given 30 minutes
before SCI, followed by daily administration of drug for 7 days. Post trau
matic neurological recovery was recorded daily for 10 days using a modified
Tarlov score, inclined plane test and sensory and vocal score. Electrophys
iological changes were assessed using somatosensory and corticomotor evoked
potentials. The animals were sacrificed at different time intervals and th
e injured site of the spinal cord was analysed for lipid hydroperoxides (LP
H), conjugated dienes (CD) and glutathione (GSH). Neuropathological changes
in the spinal cord were assessed using light microscopy. The rats exposed
to compression injury alone showed a maximum neurological deficit at 24 hr
and then a gradual recovery was observed over a period of 10 days. The rats
treated with ACR along with SCI showed poor or no recovery over a period o
f 10 days. Our electrophysiological and histopathological studies also conf
irmed that concomitant exposure to ACR produces a significant deleterious e
ffect on the recovery from SCI. SCI induced increase in oxidative stress (i
ncrease in LPH and CD and decrease in GSH) is also exacerbated by ACR sugge
sting a role of free radicals.
The results of this study suggest that increased body burden of ACR may ret
ard the recovery from neurotrauma or even lead to permanent disability.